BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 15,000 shares of BioRem stock in a transaction on Thursday, August 20th. The shares were sold at an average price of C$3.82, for a total transaction of C$57,300.00. Following the completion of the sale, the director owned 397,370 shares in the company, valued at approximately C$1,517,953.40. This trade represents a 3.64% decrease in their position.
BioRem Stock Up 1.7%
Shares of BioRem stock opened at C$3.69 on Tuesday. The company has a current ratio of 2.04, a quick ratio of 1.08 and a debt-to-equity ratio of 14.17. BioRem Inc. has a 12-month low of C$1.87 and a 12-month high of C$3.95. The company has a market cap of C$59.91 million, a P/E ratio of 10.98 and a beta of 0.81. The company’s fifty day simple moving average is C$3.31 and its two-hundred day simple moving average is C$3.00.
About BioRem
Further Reading
- Five stocks we like better than BioRem
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
